K Hopf

4.1k total citations
12 papers, 202 citations indexed

About

K Hopf is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, K Hopf has authored 12 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Internal Medicine and 1 paper in Surgery. Recurrent topics in K Hopf's work include Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Cardiac Arrhythmias and Treatments (3 papers). K Hopf is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Cardiac Arrhythmias and Treatments (3 papers). K Hopf collaborates with scholars based in United States, Canada and Belgium. K Hopf's co-authors include Žhong Yuan, Manesh R. Patel, Nicholas Sicignano, W. Frank Peacock, Troy C. Sarich, Shujian Wu, Daniel Yannicelli, Larry E. Fields, W. Frank Peacock and Alexander G.G. Turpie and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

K Hopf

10 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Hopf United States 5 160 111 21 20 18 12 202
Carmen Olga Torre United States 4 43 0.3× 23 0.2× 22 1.0× 5 0.3× 4 0.2× 4 95
Milton Santamaría Ecuador 4 58 0.4× 5 0.0× 26 1.2× 13 0.7× 51 2.8× 4 147
Sarah Traullé France 8 220 1.4× 36 0.3× 2 0.1× 16 0.9× 17 275
Lucie Valembois France 4 321 2.0× 3 0.0× 26 1.2× 12 0.6× 10 0.6× 7 371
Heidi Zakoul United States 5 23 0.1× 15 0.1× 10 0.5× 1 0.1× 11 0.6× 11 95
Elizabeth Iveson United Kingdom 4 28 0.2× 12 0.1× 5 0.2× 2 0.1× 6 0.3× 10 57
Arvind Prabhu India 4 8 0.1× 10 0.1× 20 1.0× 2 0.1× 27 1.5× 15 167
John Hayes United States 6 239 1.5× 3 0.0× 7 0.3× 3 0.1× 15 0.8× 12 306
Per Anton Sirnes Norway 7 71 0.4× 8 0.1× 2 0.1× 2 0.1× 29 1.6× 13 176
Michal Širanec Czechia 6 80 0.5× 5 0.0× 5 0.2× 5 0.3× 11 150

Countries citing papers authored by K Hopf

Since Specialization
Citations

This map shows the geographic impact of K Hopf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Hopf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Hopf more than expected).

Fields of papers citing papers by K Hopf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Hopf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Hopf. The network helps show where K Hopf may publish in the future.

Co-authorship network of co-authors of K Hopf

This figure shows the co-authorship network connecting the top 25 collaborators of K Hopf. A scholar is included among the top collaborators of K Hopf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Hopf. K Hopf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Patel, Manesh R., et al.. (2018). Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation. Clinical and Experimental Emergency Medicine. 5(1). 43–50.
2.
Kwong, Louis M., Alexander G.G. Turpie, W. Frank Peacock, et al.. (2017). A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. Current Medical Research and Opinion. 33(9). 1717–1723. 4 indexed citations
3.
Peacock, W. Frank, et al.. (2016). CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban. Annals of Emergency Medicine. 69(5). 541–550.e1. 9 indexed citations
4.
Peacock, W. Frank, et al.. (2016). Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus. The American Journal of Cardiology. 119(5). 753–759. 12 indexed citations
5.
Peacock, W. Frank, et al.. (2016). Major Bleeding in Patients Taking Rivaroxaban for VTE Treatment. CHEST Journal. 150(4). 286A–286A. 2 indexed citations
6.
Peacock, W. Franklin, et al.. (2016). 41 Major Bleeding in VTE Patients Treated With Rivaroxaban: An Analysis of Patients With Select Characteristics. Annals of Emergency Medicine. 68(4). S18–S18.
7.
Khorana, Alok A., W. Frank Peacock, Žhong Yuan, et al.. (2016). Major Bleeding Events Among Cancer and Non-Cancer Patients Taking Rivaroxaban for Venous Thromboembolism Treatment in a Department of Defense Health System Cohort. Blood. 128(22). 1447–1447. 4 indexed citations
8.
Hopf, K, et al.. (2015). Use and Perceived Effectiveness of Complementary and Alternative Medicine to Treat and Manage the Symptoms of Autism in Children: A Survey of Parents in a Community Population. The Journal of Alternative and Complementary Medicine. 22(1). 25–32. 34 indexed citations
9.
Patel, Manesh R., et al.. (2015). POST-MARKETING PHARMACOVIGILANCE STUDY FOR THE ACTIVE DETECTION AND EVALUATION OF MAJOR BLEEDING IN RIVAROXABAN USERS WITH NON-VALVULAR ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 65(10). A281–A281. 8 indexed citations
10.
11.
Peacock, W. Frank, Manesh R. Patel, Nicholas Sicignano, et al.. (2015). Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban. Clinical Cardiology. 38(2). 63–68. 127 indexed citations
12.
Hopf, K, Larry E. Fields, Troy C. Sarich, et al.. (2014). 40 Detection and Evaluation of Major Bleeding in Atrial Fibrillation or Total Hip or Knee Replacement Patients Treated with Rivaroxaban. Annals of Emergency Medicine. 64(4). S15–S15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Olga Torre Breakdown of academic impact, for papers by Milton Santamaría Breakdown of academic impact, for papers by Sarah Traullé Breakdown of academic impact, for papers by Lucie Valembois Breakdown of academic impact, for papers by Heidi Zakoul Breakdown of academic impact, for papers by Elizabeth Iveson Breakdown of academic impact, for papers by Arvind Prabhu Breakdown of academic impact, for papers by John Hayes Breakdown of academic impact, for papers by Per Anton Sirnes Breakdown of academic impact, for papers by Michal Širanec
Rankless by CCL
2026